APA

de Macedo M. P., de Melo F. M., Ribeiro J. d. S., de Mello C. A. L., de Souza Begnami M. D. F., Soares F. A., Carraro D. M. & da Cunha I. W. (20150410). RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions. : Oncoscience.

Chicago

de Macedo Mariana Petaccia, de Melo Fernanda Machado, Ribeiro Júlia da Silva, de Mello Celso Abdon Lopes, de Souza Begnami Maria Dirlei Ferreira, Soares Fernando Augusto, Carraro Dirce Maria and da Cunha Isabela Werneck. 20150410. RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions. : Oncoscience.

Harvard

de Macedo M. P., de Melo F. M., Ribeiro J. d. S., de Mello C. A. L., de Souza Begnami M. D. F., Soares F. A., Carraro D. M. and da Cunha I. W. (20150410). RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions. : Oncoscience.

MLA

de Macedo Mariana Petaccia, de Melo Fernanda Machado, Ribeiro Júlia da Silva, de Mello Celso Abdon Lopes, de Souza Begnami Maria Dirlei Ferreira, Soares Fernando Augusto, Carraro Dirce Maria and da Cunha Isabela Werneck. RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions. : Oncoscience. 20150410.